These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23767354)

  • 1. Simultaneous determination of sitagliptin and metformin in their pharmaceutical formulation.
    Rezk MR; Riad SM; Mahmoud GY; Abdel Aleem AA
    J AOAC Int; 2013; 96(2):301-6. PubMed ID: 23767354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of smart spectrophotometric methods for simultaneous determination of sitagliptin phosphate and metformin hydrochloride in their binary mixture.
    Lotfy HM; Mohamed D; Mowaka S
    Spectrochim Acta A Mol Biomol Spectrosc; 2015; 149():441-51. PubMed ID: 25978011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a rapid and economical RP-HPLC method for simultaneous determination of metformin hydrochloride and sitagliptin phosphate monohydrate: Greenness evaluation using AGREE score.
    Raza A; Murtaza SH; Hanif S; Iqbal J; Ali I; Aftab T; Shakir R; Bedar R; Syed MA
    Pak J Pharm Sci; 2022 Jan; 35(1):15-21. PubMed ID: 35221267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An efficient RP-HPLC-based approach for simultaneous determination of sitagliptin and metformin HCl in pharmaceutical drug formulation.
    Ali M; Shah MR; Zairov R; Zafar S; Ali SI; Ansar F; Uddin KM; Akylbekov N
    Pak J Pharm Sci; 2024 May; 37(3):491-498. PubMed ID: 39340841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrophotometric Determination of Metformin in Different Pharmaceutical Combinations With Glipizide or Sitagliptin in Presence of Toxic Impurities of Metformin.
    Abdallah FF; Magdy F; Abdelaleem EA; Emam AA
    J AOAC Int; 2022 Apr; 105(3):657-664. PubMed ID: 34927693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrophotometric and HPLC determinations of anti-diabetic drugs, rosiglitazone maleate and metformin hydrochloride, in pure form and in pharmaceutical preparations.
    Onal A
    Eur J Med Chem; 2009 Dec; 44(12):4998-5005. PubMed ID: 19781822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid chromatographic determination of sitagliptin either alone or in ternary mixture with metformin and sitagliptin degradation product.
    El-Bagary RI; Elkady EF; Ayoub BM
    Talanta; 2011 Jul; 85(1):673-80. PubMed ID: 21645757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(3-4):167-84. PubMed ID: 23457958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HPLC determination of metformin hydrochloride-related substances].
    Wang LR; Huang MZ; Zhu SH
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 34(4):368-71. PubMed ID: 16059989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous quantitation of metformin and sitagliptin from mouse and human dried blood spots using laser diode thermal desorption tandem mass spectrometry.
    Swales JG; Gallagher RT; Denn M; Peter RM
    J Pharm Biomed Anal; 2011 Jun; 55(3):544-51. PubMed ID: 21435813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Method for Simultaneous Estimation of Metformin and Sitagliptin in Human Plasma by LC-MS-MS and Its Application in a Bioequivalence Study.
    Reddy S; Ahmed I; Ahmad I; Mukhopadhyay A; Thangam S
    J Chromatogr Sci; 2015 Oct; 53(9):1549-56. PubMed ID: 25987553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive UHPLC-MS screening methods for the analysis of triazolopyrazine precursor and its genotoxic nitroso-derivative in sitagliptin pharmaceutical formulation.
    Jireš J; Douša M; Gibala P; Doubský J; Pěček D; Mervart D; Kluk A; Veseli A; Kalášek S; Řezanka P
    J Pharm Biomed Anal; 2024 Jan; 238():115861. PubMed ID: 37976984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Janumet: a combination product suitable for use in patients with Type 2 diabetes.
    Reynolds JK; Neumiller JJ; Campbell RK
    Expert Opin Investig Drugs; 2008 Oct; 17(10):1559-65. PubMed ID: 18808315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicinal Chemistry of Incretin Mimetics and DPP-4 Inhibitors.
    Zettl H; Schubert-Zsilavecz M; Steinhilber D
    ChemMedChem; 2010 Feb; 5(2):179-85. PubMed ID: 20029928
    [No Abstract]   [Full Text] [Related]  

  • 15. Sitagliptin: results from clinical practice.
    Maffioli P; Derosa G
    Curr Med Res Opin; 2013 Nov; 29(11):1483-5. PubMed ID: 23971498
    [No Abstract]   [Full Text] [Related]  

  • 16. Sitagliptin with metformin: profile of a combination for the treatment of type 2 diabetes.
    Gallwitz B
    Drugs Today (Barc); 2007 Oct; 43(10):681-9. PubMed ID: 17987221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic evaluation of sitagliptin plus metformin.
    Scheen AJ
    Expert Opin Drug Metab Toxicol; 2010 Oct; 6(10):1265-76. PubMed ID: 20707611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of dissolution media pH and USP1 basket speed on erosion and disintegration characteristics of immediate release metformin hydrochloride tablets.
    Desai D; Wong B; Huang Y; Tang D; Hemenway J; Paruchuri S; Guo H; Hsieh D; Timmins P
    Pharm Dev Technol; 2015; 20(5):540-5. PubMed ID: 24621340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations in inflammatory biomarkers following the addition of sitagliptin in patients with type 2 diabetes not controlled with metformin.
    Derosa G; Carbone A; D'Angelo A; Querci F; Fogari E; Cicero AF; Maffioli P
    Intern Med; 2013; 52(19):2179-87. PubMed ID: 24088749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function.
    Derosa G; Carbone A; D'Angelo A; Querci F; Fogari E; Cicero AF; Maffioli P
    Expert Opin Pharmacother; 2012 Dec; 13(17):2433-42. PubMed ID: 23061989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.